Results 281 to 290 of about 132,395 (346)

Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis. [PDF]

Front Pharmacol
Zheng Y, Zhang F, Li X, Zhang X, Zhong Y.   +4 more
europepmc   +1 more source

SAFETY AND EFFICACY OF PHARMACOLOGICAL VITREOLYSIS BY INTRAVITREAL INJECTION OF HYALURONIDASE

, 2015
Rajalingam Vairagyam, B Karunakar, Sabiha Tabassum, Rao B Y, Lokabhi Reddy J M   +4 more
openalex   +1 more source

Systemic Inflammation in Retinal Vein Occlusion and Its Role in Clinical Outcomes of Secondary Macular Edema. [PDF]

J Clin Med
Böhm EW, Wolfrum P, Welzel AM, Schuster AK, Wagner FM, Gericke A, Lorenz K, Stoffelns B, Korb CA.   +8 more
europepmc   +1 more source

Brolucizumab versus aflibercept in treating exudative age-related macular degeneration: a 12-month pro re nata regimen. [PDF]

Sci Rep
Kikushima W, Sakurada Y, Fukuda Y, Yoneyama S, Kotoda Y, Tsuru DV, Kashiwagi K.   +6 more
europepmc   +1 more source

Bilateral Sterile Intraocular Inflammation Following Intravitreal Aflibercept 8 mg Injections: A Case Report. [PDF]

Reports (MDPI)
Cohen R, Kerman T, Trivizki O.
europepmc   +1 more source

Ultrastructural and Immunohistochemical Study on the Nephrotoxicity Following Intravitreal Administration of the Antifungal Agents Voriconazole and Micafungin in New Zealand White Rabbits. [PDF]

Int J Mol Sci
Karachrysafi S, Karakousis VA, Liatsos A, Kavvadas D, Ioannou D, Anastasiadou P, Kofidou E, Karampatakis V, Sioga A, Raikos N, Papamitsou T.   +10 more
europepmc   +1 more source

Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study). [PDF]

Clin Ophthalmol
Chakraborty S, Sheth JU, Ganguly S, Reddy R.   +3 more
europepmc   +1 more source

Persistent macular edema, elusive cause. [PDF]

Indian J Ophthalmol
Gupta A, Panneerselvam S, Sreenivasan J.
europepmc   +1 more source

Association of Molar Dose and Early Retinochoroidal Blood Flow Changes After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy. [PDF]

Invest Ophthalmol Vis Sci
Kato N, Haruta M, Arai R, Nagae A, Sato K, Furushima K, Yoshida S.   +6 more
europepmc   +1 more source

Alpha-Gal Syndrome Allergy to Intravitreal Administration of Anti-Vascular Endothelial Growth Factor Agents. [PDF]

J Vitreoretin Dis
Zhang E, Bylund R, Zhang A, Massop D.
europepmc   +1 more source